Evidence map›Paper›PMID 22436128›Full record

ArticleEnvironmental health perspectives2012

Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study.

Giovanni Leonardi, Marie Vahter, Felicity Clemens, Walter Goessler, Eugen Gurzau, Kari Hemminki, Rupert Hough, Kvetoslava Koppova, Rajiv Kumar, Peter Rudnai and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 4 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 4 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Exposure to Trace Elements and Risk of Skin Cancer: A Systematic Review of Epidemiologic Studies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Baseline comorbidities in a skin cancer prevention trial in Bangladesh.European journal of clinical investigation · 2013
    Trial
  7. Article
  8. Article
  9. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  10. Article
  11. Ambient UVR and Environmental Arsenic Exposure in Relation to Cutaneous Melanoma in Iowa.International journal of environmental research and public health · 2022
    Article
  12. Review
  13. Article
  14. Biomonitoring of metals and trace elements in urine of central Ethiopian populations.International journal of hygiene and environmental health · 2019
    Article
  15. Health effects among a cohort exposed to low-level arsenic in a geothermal area of Tuscany, Italy.International archives of occupational and environmental health · 2018
    Article
  16. Article
  17. Assessment of human dietary exposure to arsenic through rice.The Science of the total environment · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 8 countries.

Giovanni LeonardiCentre for Radiation, Chemical and Environmental Hazards, Health Protection Agency, Chilton, United Kingdom.
Marie Vahter
Felicity Clemens
Walter Goessler
Eugen Gurzau
Kari Hemminki
Rupert Hough
Kvetoslava Koppova
Rajiv Kumar
Peter Rudnai
Simona Surdu
Tony Fletcher
London School of Hygiene & Tropical Medicine · GBGerman Cancer Research Center · DEAgricultural Biotechnology Institute · HUAlbany State University · USBabeș-Bolyai University · ROJames Hutton Institute · GBKarolinska Institutet · SEPublic Health Authority of the Slovak Republic · SKUniversity of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInorganic arsenic (iAs) is a potent carcinogen, but there is a lack of information about cancer risk for concentrations < 100 μg/L in drinking water.

objectivesWe aimed to quantify skin cancer relative risks in relation to iAs exposure < 100 μg/L and the modifying effects of iAs metabolism.

methodsThe Arsenic Health Risk Assessment and Molecular Epidemiology (ASHRAM) study, a case-control study, was conducted in areas of Hungary, Romania, and Slovakia with reported presence of iAs in groundwater. Consecutively diagnosed cases of basal cell carcinoma (BCC) of the skin were histologically confirmed; controls were general surgery, orthopedic, and trauma patients who were frequency matched to cases by age, sex, and area of residence. Exposure indices were constructed based on information on iAs intake over the lifetime of participants. iAs metabolism status was classified based on urinary concentrations of methylarsonic acid (MA) and dimethylarsinic acid (DMA). Associations were estimated by multivariable logistic regression.

resultsA total of 529 cases with BCC and 540 controls were recruited for the study. BCC was positively associated with three indices of iAs exposure: peak daily iAs dose rate, cumulative iAs dose, and lifetime average water iAs concentration. The adjusted odds ratio per 10-μg/L increase in average lifetime water iAs concentration was 1.18 (95% confidence interval: 1.08, 1.28). The estimated effect of iAs on cancer was stronger in participants with urinary markers indicating incomplete metabolism of iAs: higher percentage of MA in urine or a lower percentage of DMA.

conclusionWe found a positive association between BCC and exposure to iAs through drinking water with concentrations < 100 μg/L.

Indexed as

ArsenicBasal Cell CarcinomaCase-Control StudiesEnvironmental ExposureHungaryLogistic ModelsRisk AssessmentRisk FactorsRomaniaSkin NeoplasmsSlovakiaArsenic

Identifiers

PMID22436128
PMCPMC3346769
OpenAlexW2048874346

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.